FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

The FDA has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test. The post FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo appeared first on Medical Device Network.

Apr 3, 2025 - 10:00
 0
FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo
The FDA has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test.

The post FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo appeared first on Medical Device Network.